Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 6, 2013, Pages

  Goarant, Cyrille ^a   Bourhy, Pascale ^b   D'Ortenzio, Eric ^a   Dartevelle, Sylvie ^b   Mauron, Carine ^a   Soupé Gilbert, Marie Estelle ^a   Bruyère Ostells, Lilian ^a   Gourinat, Ann Claire ^a   Picardeau, Mathieu ^b   Nato, Faridabano ^b   Chanteau, Suzanne ^a  

^a Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEAT TOLERANCE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; NONHUMAN; PREDICTIVE VALUE; PREVALENCE; PUBLIC HEALTH PROBLEM; RAPID TEST; REPRODUCIBILITY; RISK; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SHELF LIFE;

EID: 84879542140     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002289     Document Type: Article

References (46)

1. Hartskeerl RA, Collares-Pereira M, Ellis WA, (2011) Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17: 494-501.
2. Adler B, de la Pena Moctezuma A, (2009) Leptospira and leptospirosis. Vet Microbiol 140: 287-296.
3. McBride AJ, Athanazio DA, Reis MG, Ko AI, (2005) Leptospirosis. Curr Opin Infect Dis 18: 376-386.
4. Levett PN, (2001) Leptospirosis. Clinical Microbiology Reviews 14: 296-326.
5. Lau C, Smythe L, Weinstein P, (2010) Leptospirosis: an emerging disease in travellers. Travel Med Infect Dis 8: 33-39.
6. Leshem E, Segal G, Barnea A, Yitzhaki S, Ostfeld I, et al. (2010) Travel-related leptospirosis in Israel: a nationwide study. Am J Trop Med Hyg 82: 459-463.
7. Suputtamongkol Y, Pongtavornpinyo W, Lubell Y, Suttinont C, Hoontrakul S, et al. (2010) Strategies for Diagnosis and Treatment of Suspected Leptospirosis: A Cost-Benefit Analysis. PLoS Negl Trop Dis 4: e610.
8. World Health Organization WHO, International Leptospirosis Society ILS (2003) Human Leptospirosis: guidance for diagnosis, surveillance and control; Society WHO-IL, editor: World Health Organization. 122 p.
9. Berlioz-Arthaud A, Kiedrzynski T, Singh N, Yvon JF, Roualen G, et al. (2007) Multicentre survey of incidence and public health impact of leptospirosis in the Western Pacific. Trans R Soc Trop Med Hyg 101: 714-721.
10. Goarant C, Laumond-Barny S, Perez J, Vernel-Pauillac F, Chanteau S, et al. (2009) Outbreak of leptospirosis in New Caledonia: diagnosis issues and burden of disease. Tropical Medicine and International Health 14: 926-929.
11. Bourhy P, Nato F, Chanteau S, Goarant C, Dartevelle S, et al. (2012) European Patent EP123062150: Use of Leptospira fainei serovar Hurstridge bacteria for diagnosing leptospirosis. In: European Patent Office, editor.
12. Chanteau S, Dartevelle S, Mahamane AE, Djibo S, Boisier P, et al. (2006) New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Med 3: e337.
13. World Health Organization WHO (1999) WHO recommended standards and strategies for surveillance prevention and control of communicable diseases: Leptospirosis: World Health Organization, W.H.O.
14. Hochedez P, Rosine J, Theodose R, Abel S, Bourhy P, et al. (2011) Outbreak of leptospirosis after a race in the tropical forest of martinique. Am J Trop Med Hyg 84: 621-626.
15. Kirkwood TB, (1977) Predicting the stability of biological standards and products. Biometrics 33: 736-742.
16. Paek SH, Lee SH, Cho JH, Kim YS, (2000) Development of rapid one-step immunochromatographic assay. Methods 22: 53-60.
17. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, et al. (2010) Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol 8: S17-29.
18. Jaeschke R, Guyatt GH, Sackett DL, (1994) Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271: 703-707.
19. Simel DL, Samsa GP, Matchar DB, (1991) Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44: 763-770.
20. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM, (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135.
21. Armitage P, Berry G (1994) Statistical methods in medical research. 3rd edition. Boston: Blackwell Scientific Publications.
22. Perez J, Goarant C, (2010) Rapid Leptospira identification by direct sequencing of the diagnostic PCR products in New Caledonia. BMC Microbiol 10: 325.
23. Perolat P, Chappel RJ, Adler B, Baranton G, Bulach DM, et al. (1998) Leptospira fainei sp. nov., isolated from pigs in Australia. International Journal of Systematic Bacteriology 48: 851-858.
24. Chappel RJ, Khalik DA, Adler B, Bulach DM, Faine S, et al. (1998) Serological titres to Leptospira fainei serovar hurstbridge in human sera in Australia. Epidemiol Infect 121: 473-475.
25. Smits HL, Eapen CK, Sugathan S, Kuriakose M, Gasem MH, et al. (2001) Lateral-flow assay for rapid serodiagnosis of human leptospirosis. Clin Diagn Lab Immunol 8: 166-169.
26. Desakorn V, Wuthiekanun V, Thanachartwet V, Sahassananda D, Chierakul W, et al. (2012) Accuracy of a Commercial IgM ELISA for the Diagnosis of Human Leptospirosis in Thailand. Am J Trop Med Hyg 86: 524-527.
27. Effler PV, Bogard AK, Domen HY, Katz AR, Higa HY, et al. (2002) Evaluation of eight rapid screening tests for acute leptospirosis in Hawaii. J Clin Microbiol 40: 1464-1469.
28. Blacksell SD, Smythe L, Phetsouvanh R, Dohnt M, Hartskeerl R, et al. (2006) Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin M antibodies in Laos. Clin Vaccine Immunol 13: 1166-1169.
29. Limmathurotsakul D, Turner EL, Wuthiekanun V, Thaipadungpanit J, Suputtamongkol Y, et al. (2012) Fool's gold: why imperfect reference tests are undermining the evaluation of novel diagnostics. A re-evaluation of five diagnostic tests for leptospirosis. Clin Infect Dis 55: 322-31.
30. Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, et al. (2003) Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol 41: 803-809.
31. Levett PN, (2003) Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 36: 447-452.
32. Murray CK, Gray MR, Mende K, Parker TM, Samir A, et al. (2011) Use of patient-specific Leptospira isolates in the diagnosis of leptospirosis employing microscopic agglutination testing (MAT). Trans R Soc Trop Med Hyg 105: 209-213.
33. Cumberland P, Everard CO, Levett PN, (1999) Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am J Trop Med Hyg 61: 731-734.
34. Brandao AP, Camargo ED, da Silva ED, Silva MV, Abrao RV, (1998) Macroscopic agglutination test for rapid diagnosis of human leptospirosis. J Clin Microbiol 36: 3138-3142.
35. Goris MGA, Leeflang MMG, Boer KR, Goeijenbier M, Van Gorp ECM, et al. (2012) Establishment of valid laboratory case definition for human leptospirosis. J Bacteriol Parasitol 3: 132.
36. Smythe LD, Wuthiekanun V, Chierakul W, Suputtamongkol Y, Tiengrim S, et al. (2009) The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am J Trop Med Hyg 81: 695-697.
37. Aviat F, Rochereau-Roulet S, Branger C, Estavoyer JM, Chatrenet B, et al. (2010) Synthetic peptide issued from Hap1/LipL32 for new early serodiagnosis of human leptospirosis. Comp Immunol Microbiol Infect Dis 33: 375-387.
38. Doungchawee G, Kositanont U, Niwetpathomwat A, Inwisai T, Sagarasaeranee P, et al. (2008) Early Diagnosis of Leptospirosis by IgM Immunoblot Testing. Clin Vaccine Immunol 15: 492-498.
39. Chirathaworn C, Kaewopas Y, Poovorawan Y, Suwancharoen D, (2007) Comparison of a slide agglutination test, LeptoTek Dri-Dot, and IgM-ELISA with microscopic agglutination test for Leptospira antibody detection. Southeast Asian J Trop Med Public Health 38: 1111-1114.
40. Levett PN, Branch SL, Whittington CU, Edwards CN, Paxton H, (2001) Two methods for rapid serological diagnosis of acute leptospirosis. Clin Diagn Lab Immunol 8: 349-351.
41. Winslow WE, Merry DJ, Pirc ML, Devine PL, (1997) Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J Clin Microbiol 35: 1938-1942.
42. Silva MV, Camargo ED, Batista L, Vaz AJ, Brandao AP, et al. (1995) Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. J Trop Med Hyg 98: 268-272.
43. Amilasan AT, Ujiie M, Suzuki M, Salva E, Belo MCP, et al. (2012) Outbreak of Leptospirosis after Flood, the Philippines, 2009. Emerging Infectious Diseases 18: 91-94.
44. Smits HL, Ananyina YV, Chereshsky A, Dancel L, Lai AFRF, et al. (1999) International multicenter evaluation of the clinical utility of a dipstick assay for detection of Leptospira-specific immunoglobulin M antibodies in human serum specimens. J Clin Microbiol 37: 2904-2909.
45. Truong KN, Coburn J, (2012) The emergence of severe pulmonary hemorrhagic leptospirosis: questions to consider. Front Cell Infect Microbiol 1: e24.
46. Ellis T, Imrie A, Katz AR, Effler PV, (2008) Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001-2002. Vector Borne Zoonotic Dis 8: 541-547.